Cambrex Corporation News Headlines

CBM 
$17.82
*  
0.06
0.34%
Get CBM Alerts
*Delayed - data as of Oct. 22, 2014 11:15 ET  -  Find a broker to begin trading CBM now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    CBM Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Commit To Buy Cambrex Corp At $15, Earn 11.3% Annualized Using Options
10/16/2014 11:37:20 AM - BNK Invest


Halozyme's PEGPH20 Receives FDA Orphan Drug Designation - Analyst Blog
10/7/2014 5:40:00 PM - Zacks.com


Pluristem Therapeutics, Inc. (PSTI) in Focus: Stock Up 7.4% - Tale of the Tape
10/7/2014 8:44:00 AM - Zacks.com


Alexion Pharmaceuticals (ALXN) in Focus: Stock Rises 6.0% - Tale of the Tape
10/6/2014 8:44:00 AM - Zacks.com


Weakness Seen in Vital Therapies (VTL): Stock Falls 6.3% - Tale of the Tape
10/6/2014 8:42:00 AM - Zacks.com


CorMedix Files IND Application for Neutrolin in the US - Analyst Blog
9/30/2014 5:10:00 PM - Zacks.com


Ambit Biosciences (AMBI) Soars: Stock Adds 87.1% - Tale of the Tape
9/30/2014 9:46:00 AM - Zacks.com


Immunomedics (IMMU) Jumps: Stock Adds 9.1% is Session - Tale of the Tape
9/30/2014 9:39:00 AM - Zacks.com


Raptor Pharmaceuticals (RPTP) Crumbles: Stock Falls by 7.2% - Tale of the Tape
9/30/2014 8:36:00 AM - Zacks.com


Alimera/pSivida's Iluvien Receives FDA Approval for DME - Analyst Blog
9/29/2014 5:55:00 PM - Zacks.com


Repros Therapeutics (RPRX) Worth Watching: Stock Up 17% - Tale of the Tape
9/29/2014 9:46:00 AM - Zacks.com


Celldex (CLDX) Up on Pilot Study Initiation on CDX-301 - Analyst Blog
9/26/2014 5:20:00 PM - Zacks.com


Myriad Genetics Poised on Strong myRisk, Overseas Results - Analyst Blog
9/26/2014 3:20:00 PM - Zacks.com


Merrimack Pharmaceuticals (MACK) Soars: Stock Adds 7.4% is Session - Tale of the Tape
9/26/2014 9:39:00 AM - Zacks.com


Rexahn Pharmaceuticals (RNN) Jumps: Stock Gains 10.2% - Tale of the Tape
9/26/2014 9:25:00 AM - Zacks.com


Genomic Health Upbeat on Strong International Performance - Analyst Blog
9/25/2014 3:00:00 PM - Zacks.com


Cambrex (CBM) Is in Oversold Territory: What's Next? - Tale of the Tape
9/25/2014 9:55:09 AM - Zacks.com


Acceleron Pharma (XLRN) Jumps: Stock Rises 12.8% - Tale of the Tape
9/24/2014 9:39:00 AM - Zacks.com


Sangamo Biosciences (SGMO) Jumps: Stock Rises 5.4% - Tale of the Tape
9/24/2014 8:51:00 AM - Zacks.com


Integra Freedom Wrist's Commercial Availability Falls Flat - Analyst Blog
9/23/2014 3:10:00 PM - Zacks.com


OncoMed Pharmaceuticals (OMED) Jumps: Stock Up 5.4% - Tale of the Tape
9/23/2014 8:51:00 AM - Zacks.com


Integra to Buy Medtronic's MicroFrance, Xomed; Shares Up - Analyst Blog
9/22/2014 3:10:00 PM - Zacks.com


Cytori Therapeutics (CYTX) Jumps: Stock Rises 6.4% - Tale of the Tape
9/22/2014 9:39:00 AM - Zacks.com


Vertex Pharmaceuticals (VRTX) Jumps: Stock Rises 6.6% - Tale of the Tape
9/22/2014 8:51:00 AM - Zacks.com


Halozyme's PEGPH20 Study S1313 Clinical Hold Lifted by FDA - Analyst Blog
9/19/2014 5:20:00 PM - Zacks.com